(Q40041917)

16 September 2017

title

Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes (English)

1 reference

16 September 2017

1 reference

type 2 diabetes

9 December 2023

12

Satu Männistö

1 reference

16 September 2017

11

Annika Wennerström

1 reference

16 September 2017

18

Markus Perola

1 reference

16 September 2017

13

Veikko Salomaa

1 reference

16 September 2017

14

Aki Havulinna

1 reference

16 September 2017

16

James F Wilson

1 reference

16 September 2017

Toma Keser

1

1 reference

16 September 2017

Ivan Gornik

2

1 reference

16 September 2017

Frano Vučković

3

1 reference

16 September 2017

Najda Selak

4

1 reference

16 September 2017

Tamara Pavić

5

1 reference

16 September 2017

Edita Lukić

6

1 reference

16 September 2017

Ivan Gudelj

7

1 reference

16 September 2017

Hrvoje Gašparović

8

1 reference

16 September 2017

Bojan Biočina

9

1 reference

16 September 2017

Therese Tilin

10

1 reference

16 September 2017

Wei Wang

15

1 reference

16 September 2017

Nishi Charutvedi

17

1 reference

16 September 2017

Harry Campbell

19

1 reference

16 September 2017

Gordan Lauc

20

1 reference

16 September 2017

Olga Gornik

21

1 reference

16 September 2017

publication date

13 September 2017

1 reference

16 September 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-017-4426-9

16 September 2017

exact match

0 references

cites work

Hyperglycemia in sepsis is a risk factor for development of type II diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Complex genetic regulation of protein glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Sweetening the pot: adding glycosylation to the biomarker discovery equation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Altered glycosylation of alpha1-acid glycoprotein in patients with inflammation and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Thirty-five-year trends in cardiovascular risk factors in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Runs of homozygosity in European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Southall And Brent REvisited: Cohort profile of SABRE, a UK population-based comparison of cardiovascular disease and diabetes in people of European, Indian Asian and African Caribbean origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

N-glycan remodeling on glucagon receptor is an effector of nutrient sensing by the hexosamine biosynthesis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4426-9

Studies on microheterogeneity of acute-phase proteins in rheumatoid arthritis by using crossed affinoimmuno-electrophoresis with free concanavalin A

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28905229

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Stability of N-glycan profiles in human plasma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28905229

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association of N-Glycosylation with Breast Carcinoma and Systemic Features Using High-Resolution Quantitative UPLC

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28905229

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-017-4426-9

1 reference

16 September 2017

1 reference